Poultry Diagnostics Market Report 2026-2031, By Product Type, Test Type, and Geo

Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031

USD 0.18B

MARKET SIZE, 2026

USD 0.25B

MARKET SIZE, 2031

7.1%

CAGR (2026-2031)

2026-2031

FORECAST PERIOD

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global poultry diagnostics market, valued at USD 0.17BN in 2025, stood at USD 0.18BN in 2026 and is projected to advance at a resilient CAGR of 7.1% from 2026 to 2031, culminating in a forecasted valuation of USD 0.25BN by the end of the period. This growth is driven by an increase in cases of both transboundary and endemic poultry diseases, the intensification of commercial poultry production, and a greater emphasis on early disease detection and flock health management. Additionally, the market is supported by stricter biosecurity regulations, increased surveillance programs for avian influenza and other reportable diseases, and a rise in the use of advanced diagnostic techniques such as real-time PCR, multiplex assays, and automated ELISA systems.

KEY TAKEAWAYS

MARKET SNAPSHOT:
Base Year Market Size (2025): USD 0.17 Billion
Current Market Size (2026): USD 0.18 Billion
Forecast Market Size (2031): USD 0.25 Billion
CAGR (2026�2031): 7.1%
SEGMENT LEADERSHIP:
By Region: Asia Pacific is estimated to register the highest CAGR of 7.1% during the forecast period.
By Product Type: Consumables & Reagents is expected to register the highest CAGR of 7.5%.
By Test Type: PCR-based diagnostics is expected to dominate the market with a share of 47.1% in 2025.
By Disease Type: Avian influenza is projected to grow at the fastest rate from 2026 to 2031.
By Poultry Type: Broilers in the PCR-based diagnostics market accounted for the largest share of 42.5% in 2025.
By Sample Type: Swabs is expected to register the highest CAGR of 9.5% during the forecast period.
By End User: Veterinary diagnostic laboratories dominated the market with a share of 51.3% in 2025.
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
IDEXX Laboratories, Inc., Zoetis Services LLC, and Thermo Fisher Scientific Inc. were identified as star players in the poultry diagnostics market due to their extensive global reach and comprehensive product portfolios.
BioinGentech, Abbexa, and Elabscience, Inc. have distinguished themselves among startups and SMEs due to their specialized veterinary expertise and focused product capabilities.

The poultry diagnostics industry is experiencing steady growth due to the rising occurrence of infectious diseases in commercial flocks and advancements in early and accurate detection methods. The expansion of poultry production, stricter biosecurity measures, and improved knowledge among producers and veterinarians regarding disease surveillance are also contributing to the market's growth. Additionally, the development of molecular diagnostics, rapid testing methods, and automated laboratory systems, along with easier access to veterinary diagnostic services, are increasing the adoption of diagnostic solutions and driving overall market expansion.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The role of consumers in the poultry diagnostics market is influenced by several factors, including the rise in infectious disease outbreaks, the increasing need for rapid and accurate disease detection, and ongoing innovations in molecular and immunodiagnostic technologies. The primary end users of diagnostic kits, reagents, and testing platforms include veterinary diagnostic laboratories, large poultry integrators, commercial farms, and government surveillance agencies. These users depend on suppliers for reliable and high-performance testing solutions tailored for flock-level management. The growing demand for quicker turnaround times, improved surveillance efficiency, reduced economic losses, and adherence to production costs is increasingly shaping purchasing decisions in the poultry diagnostics market.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Rising incidence of transboundary & endemic diseases
Growth in commercial & industrial poultry production

RESTRAINTS

Impact
Level

High cost of advanced molecular testing platforms
Limited diagnostic infrastructure in developing regions

OPPORTUNITIES

Impact
Level

Geographic expansion in emerging poultry markets
Development of rapid point-of-care (POC) tests

CHALLENGES

Impact
Level

Rapid mutation and strain variability of viral pathogens
Limited awareness among small & backyard farmers

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising incidence of transboundary & endemic diseases

The increase in outbreaks of both transboundary and local poultry diseases, including avian influenza, Newcastle disease, infectious bronchitis, and infectious bursal disease, continues to disrupt poultry production globally. These epidemic events result in significant economic losses due to the death of large numbers of birds, reduced production, and the imposition of international trade restrictions. As a result, poultry producers, integrators, and government authorities have prioritized early detection and routine surveillance programs. The ongoing threat posed by these diseases drives the constant demand for reliable, high-sensitivity diagnostic tests that are rapid and effective in containing infections and preventing their spread from one flock or area to another.

Restraint: High cost of advanced molecular testing platforms

Molecular diagnostic technologies, such as real-time PCR and automated high-throughput systems, offer significantly higher sensitivities and faster turnaround times. However, they require substantial capital investment and technical expertise. The costs associated with equipment, reagents, maintenance, and skilled laboratory personnel can be very high, particularly for small and medium-sized poultry operations and laboratories in developing economies. This financial barrier often prevents only large integrators and well-funded diagnostic centers from adopting these technologies, which limits overall market growth and makes it challenging to enter price-sensitive regions.

Opportunity: Geographic expansion in emerging poultry markets

Emerging economies in the Asia Pacific, Africa, and Latin America are experiencing rapid growth in commercial poultry production, driven by increasing protein consumption and population growth. As these countries adopt modern farming practices, there is greater focus on biosecurity, disease control, and compliance with export standards. Simultaneously, government authorities are strengthening their national surveillance programs to contain the potential for large-scale disease outbreaks. This changing landscape presents a promising opportunity for diagnostic companies to expand their businesses by providing affordable, scalable, and market-oriented testing solutions that align with local production systems in these regions.

Challenge: Rapid mutation and strain variability of viral pathogens

Many poultry pathogens, primarily RNA viruses such as the avian influenza virus and the infectious bronchitis virus, have high mutation rates, which causes them to change genetically quite often. These changes can affect the antigenic properties and genome sequences, making existing diagnostic tests less accurate. As a result, companies that produce these tests must continuously update their primers, probes, and antibodies to maintain the sensitivity and specificity of the tests. This ongoing need for assay optimization, validation, and regulatory re-approval increases both development costs and operational complexity, making pathogen variability a persistent technical challenge in the market.

POULTRY DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Provides poultry-specific ELISA test kits (e.g., for AI, ND, IBD, IB, Mycoplasma) and molecular diagnostics solutions through its IDEXX PCR platforms	Enables high-throughput, reliable flock health screening with strong global laboratory support, improving early detection and biosecurity compliance
	Supplies VetMAX PCR kits for avian influenza and Newcastle disease, as well as real-time PCR instruments and reagents used in veterinary diagnostic laboratories	Offers validated, regulatory-aligned molecular testing solutions with scalable platforms suitable for national surveillance and export testing requirements
	Specializes in poultry-focused ELISA and PCR diagnostic kits for diseases such as AI, ND, IBD, IB, and Mycoplasma	Provides flock-level monitoring solutions with strong technical support tailored specifically to the poultry industry
	Develops and manufactures ID Screen ELISA kits and real-time PCR assays for a wide range of avian diseases, widely used in veterinary laboratories and government monitoring programs	Offers species-specific, validated assays with high sensitivity and specificity, supporting reliable disease surveillance
	Produces rapid diagnostic test kits (lateral flow assays) and ELISA kits for avian influenza and other poultry diseases, designed for on-site and laboratory use	Enables rapid, field-level screening with user-friendly formats, facilitating quick decision-making and early outbreak containment

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The poultry diagnostics market ecosystem consists of various stakeholders involved in the development, manufacturing, regulation, distribution, and use of diagnostic solutions for detecting infectious diseases in poultry. Key participants include diagnostic kit manufacturers, molecular technology providers, reagent suppliers, and research institutions that support assay development and pathogen monitoring. Regulatory authorities and government agencies play a critical role, as they are involved in validation, surveillance programs, and ensuring compliance with trade regulations, particularly for notifiable diseases like avian influenza. Distributors facilitate market access, while the end users (commercial poultry integrators, farms, and veterinary laboratories) drive demand through routine testing, outbreak management, and biosecurity compliance. The ecosystem is influenced by the prevalence of diseases, regulatory frameworks, and advancements in diagnostic technologies.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Poultry Diagnostics Market, by Product Type

Consumables & reagents comprise the largest product segment in the poultry diagnostics market because they are essential for every test conducted, resulting in continuous and recurring demand. Unlike diagnostic instruments, which are typically one-time capital purchases, products such as ELISA plates, PCR reagents, primers, probes, and rapid test strips require regular replenishment. Additionally, routine flock monitoring and extensive surveillance programs contribute to repeated usage, further solidifying their dominant market share.

Poultry Diagnostics Market, by Test Type

In 2025, PCR-based diagnostics led the market due to their ability to detect infections at very early stages with high sensitivity and accuracy. Real-time PCR diagnostics can quickly and precisely identify viruses and bacteria such as avian influenza, Newcastle disease, and Mycoplasma spp., which are key agents in outbreaks. These methods are also excellent for multiplex testing. Since they have been approved for use in notifiable diseases, their application in veterinary laboratories and government programs for disease monitoring has become widespread.

Poultry Diagnostics Market, by Disease Type

The avian influenza segment holds the largest share of the poultry diagnostics market due to the rapid spread of the disease, the significant economic losses it causes, and the strict reporting requirements associated with outbreaks. An outbreak of highly pathogenic avian influenza (HPAI) typically leads to severe poultry losses, trade bans, and culling of affected birds. In response, authorities are compelled to implement large-scale surveillance and flock testing during these outbreaks. Additionally, government-mandated monitoring programs and export certification requirements will continue to drive the demand for avian influenza diagnostic tests that are both accurate and highly sensitive.

Poultry Diagnostics Market, by Poultry Type

Broilers are the leading segment in the poultry diagnostics market, primarily due to their dominance in global poultry meat production. Their short production cycles and high stocking densities facilitate the rapid spread of diseases, necessitating frequent health monitoring and regular diagnostic testing. Additionally, major commercial broiler integrators implement well-organized surveillance programs aimed at reducing mortality rates, maintaining feed conversion efficiency, and meeting export and biosecurity standards. This focus on health and safety contributes to an increased demand for diagnostics in this segment.

Poultry Diagnostics Market, by Sample Type

Swabs hold the largest market share in the poultry diagnostics sector. They are primarily used for regular checks and the early detection of pathogens, particularly for respiratory diseases and avian influenza. Collecting samples from live birds using oropharyngeal and cloacal swabs is straightforward, less invasive, and ideal for large-scale flock screening programs. Additionally, their compatibility with PCR-based testing, along with regulatory surveillance requirements, contributes to their widespread adoption in both commercial farms and government monitoring initiatives.

Poultry Diagnostics Market, by End User

Veterinary diagnostic laboratories play a crucial role in the poultry diagnostics market, serving as key testing centers for regular surveillance, outbreak verification, and compliance with regulatory reporting. These laboratories are equipped with advanced molecular platforms, such as real-time PCR and high-throughput ELISA systems, which enable precise handling of large volumes of samples. The demand for diagnostics in this sector remains strong and high-volume, as government surveillance programs, export certification requirements, and testing by commercial integrators are primarily conducted through accredited veterinary laboratories.

REGION

Asia Pacific to be fastest-growing region in global poultry diagnostics market during forecast period

The Asia Pacific region is the fastest-growing market for poultry diagnostics. This growth is primarily driven by a large and rapidly expanding poultry production base, increasing demand for affordable animal protein, and a rise in transboundary diseases such as avian influenza. The transition to commercial-scale poultry farming in countries like China, India, Indonesia, and Vietnam has created a greater need for regular disease surveillance and strict adherence to biosecurity measures. Additionally, the strengthening of government monitoring programs, a focus on export-oriented production, and upgrades to laboratory facilities are contributing to the region's swift adoption of advanced diagnostic technologies.

POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX

In the poultry diagnostics market, IDEXX Laboratories, Inc. stands out as a dominant player, supported by its extensive portfolio of poultry-specific ELISA and PCR tests. This leadership position is reinforced by its high-throughput testing solutions, ongoing assay development, and strong collaborations with commercial integrators and veterinary laboratories for routine flock monitoring and surveillance. Meanwhile, Bio-Rad Laboratories, Inc. is emerging as a key competitor by enhancing its capabilities in advanced molecular diagnostics and microbiology technologies used to detect important poultry pathogens. Its expertise in life science research tools, coupled with a growing diagnostic assay portfolio, is helping to increase its presence in the poultry diagnostics market.

Poultry Diagnostics Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

IDEXX Laboratories, Inc. (US)
Thermo Fisher Scientific Inc. (US)
Zoetis Services LLC (US)
BioNote (South Korea)
Innovative Diagnostics (France)
Bio-Rad Laboratories, Inc. (US)
BioChek (Netherlands)
GD (Netherlands)
INDICAL BIOSCIENCE GmbH (Germany)
Shenzhen Bioeasy Biotechnology, Inc. (China)
Ring Biotechnology Co., Ltd. (China)
Bio-X Diagnostics S.A. (Belgium)
MEGACOR Diagnostik GmbH (Austria)
Gold Standard Diagnostics (Germany)
Bioneer Corporation (South Korea)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 0.17 Billion
Market Forecast in 2031 (Value)	USD 0.25 Billion
CAGR	CAGR of 7.1% from 2026–2031
Years Considered	2024–2031
Base Year	2025
Forecast Period	2026–2031
Units Considered	Value (USD Billion), Volume (Thousand Units, Thousand Tests, Thousand Animals)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	By Product Type: Consumables & Reagents Instruments By Test Type: PCR-based Diagnostics ELISA-based Diagnostics Other Diagnostic Tests By Disease Type: Avian Influenza Newcastle Disease Infectious Bronchitis Avian Mycoplasmosis Salmonellosis Infectious Bursal Disease Other Infectious Diseases By Poultry Type: Broilers Layers Breeders Turkeys Ducks & Geese Other Poultry By Sample Type: Swabs Serum/Blood Tissue Samples Environmental & Fecal Samples By End User: Veterinary Diagnostic Laboratories Integrated Poultry Producers Government & Reference Laboratories Academic & Research Institutions Other Specialized Laboratories
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: POULTRY DIAGNOSTICS MARKET REPORT CONTENT GUIDE

Poultry Diagnostics Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	Comparative analysis of key poultry diagnostic product categories, including ELISA kits, real-time PCR assays, and rapid lateral flow tests Highlighted technology trends such as multiplex PCR, portable on-farm testing, and assay sensitivity improvements, along with differentiation across major manufacturers	Enabled identification of high-demand disease segments (AI, ND, IB, IBD), technology adoption patterns, pricing dynamics, and product positioning strategies to support portfolio expansion and competitive benchmarking
Company Information	Profiled key players, including IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, INDICAL BIOSCIENCE, BioChek, IDvet, and BioNote Provided insights into poultry-specific product portfolios, molecular capabilities, geographic presence, and strategic focus areas	Delivered clarity on partnership and acquisition opportunities, competitive positioning, and investment hotspots influencing growth in poultry infectious disease diagnostics
Geographic Analysis	Provided detailed analysis on the Rest of APAC for poultry diagnostics demand Assessed country-level factors such as poultry production volumes, disease prevalence, surveillance regulations, laboratory infrastructure, and trade/export requirements	Supported regional expansion strategies by identifying priority poultry-producing markets, regulatory-driven demand, localization opportunities, and distributor partnerships to accelerate growth

RECENT DEVELOPMENTS

November 2025 : Zoetis announced the acquisition of Veterinary Pathology Group (VPG), a veterinary diagnostic laboratory network operating across the UK and Ireland. This acquisition enhances Zoetis’ diagnostics portfolio and reinforces its commitment to advancing animal health through high-quality diagnostic solutions.
February 2025 : BioChek launched the vetnord MS-H DIVA qPCR Kit, a real-time PCR assay designed to detect Mycoplasma synoviae field strains while differentiating them from the MS-H vaccine strain.
September 2024 : GD introduced updated veterinary diagnostic reagents containing inactivated H5N1 and H5N8 antigens for use in the Hemagglutination Inhibition (HI) test, supporting accurate detection of avian influenza antibodies in poultry amid ongoing global HPAI concerns.

checkmark Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Harness technological advances to revolutionize poultry diagnostics and capitalize on emerging market opportunities.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

RISING INCIDENCE OF TRANSBOUNDARY AND ENDEMIC DISEASES

4.2.1.2

GROWTH IN COMMERCIAL AND INDUSTRIAL POULTRY PRODUCTION

4.2.1.3

SHIFT TOWARD PREVENTIVE FLOCK HEALTH MANAGEMENT

4.2.1.4

TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR DIAGNOSTICS, MULTIPLEX ASSAYS, AND RAPID TESTING PLATFORMS

4.2.2

RESTRAINTS

4.2.2.1

HIGH COST OF ADVANCED MOLECULAR DIAGNOSTIC PLATFORMS AND AUTOMATED SYSTEMS

4.2.2.2

LIMITED DIAGNOSTIC INFRASTRUCTURE IN DEVELOPING REGIONS

4.2.3

OPPORTUNITIES

4.2.3.1

GEOGRAPHIC EXPANSION IN EMERGING POULTRY MARKETS

4.2.3.2

EXPANSION OF RAPID POINT-OF-CARE AND PORTABLE ON-FARM DIAGNOSTIC SOLUTIONS

4.2.4

CHALLENGES

4.2.4.1

RAPID MUTATION AND STRAIN VARIABILITY OF VIRAL PATHOGENS

4.2.4.2

LIMITED AWARENESS AMONG SMALL & BACKYARD FARMERS

4.3

UNMET NEEDS & WHITE SPACES

4.3.1

UNMET NEEDS IN POULTRY DIAGNOSTICS MARKET

4.3.2

WHITE SPACE OPPORTUNITIES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4.5.1

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

INDUSTRY TRENDS

Navigate competitive pressures and pricing dynamics shaping the global healthcare and animal health industries.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF SUPPLIERS

5.1.4

BARGAINING POWER OF BUYERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMIC INDICATORS

5.2.1

INTRODUCTION

5.2.2

GDP TRENDS & FORECAST

5.2.3

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.4

TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY

5.3

SUPPLY CHAIN ANALYSIS

5.4

VALUE CHAIN ANALYSIS

5.5

ECOSYSTEM ANALYSIS

5.6

PRICING ANALYSIS

5.6.1

AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025

5.6.2

AVERAGE SELLING PRICE TREND OF POULTRY DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025

5.6.2.1

AVERAGE SELLING PRICE TREND OF ELISA KITS & REAGENTS, BY REGION, 2023−2025

5.6.2.2

AVERAGE SELLING PRICE TREND OF PCR REAGENTS & KITS, BY REGION, 2023−2025

5.6.2.3

AVERAGE SELLING PRICE TREND OF SAMPLE PREPARATION & EXTRACTION KITS, BY REGION, 2023−2025

5.6.2.4

AVERAGE SELLING PRICE TREND OF CONTROLS & LABORATORY CONSUMABLES, BY REGION, 2023−2025

5.6.2.5

AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2023−2025

5.6.2.6

AVERAGE SELLING PRICE TREND OF ELISA READERS & WASHERS, BY REGION, 2023−2025

5.6.2.7

AVERAGE SELLING PRICE TREND OF NUCLEIC ACID EXTRACTION SYSTEMS, BY REGION, 2023−2025

5.7

TRADE ANALYSIS

5.7.1

TRADE DATA FOR HS CODE 3822

5.7.1.1

IMPORT DATA FOR HS CODE 3822

5.7.1.2

EXPORT DATA FOR HS CODE 3822

5.8

KEY CONFERENCES & EVENTS, 2026–2027

5.9

TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.10

INVESTMENT & FUNDING SCENARIO

5.11

SUCCESS STORIES & REAL-WORLD APPLICATIONS

5.11.1

AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION

5.11.2

MOLECULAR DETECTION AND CHARACTERIZATION OF AVIAN PATHOGENS USING MULTIPLEX PCR

5.11.3

MULTIPLEX PCR DETECTION OF RESPIRATORY PATHOGENS IN COMMERCIAL POULTRY FLOCKS

5.12

IMPACT OF 2025 US TARIFFS ON POULTRY DIAGNOSTICS MARKET

5.12.1

INTRODUCTION

5.12.2

KEY TARIFF RATES

5.12.3

PRICE IMPACT ANALYSIS

5.12.4

IMPACT ON COUNTRY/REGION

5.12.5

IMPACT ON END-USE INDUSTRIES

5.12.5.1

VETERINARY DIAGNOSTIC LABORATORIES

5.12.5.2

INTEGRATED POULTRY PRODUCERS

5.12.5.3

GOVERNMENT & REFERENCE LABORATORIES

5.12.5.4

ACADEMIC & RESEARCH INSTITUTIONS

5.12.5.5

OTHER SPECIALIZED LABORATORIES

STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION

Revolutionize poultry diagnostics with AI-driven precision and smart biosensor technologies.

100

6.1

TECHNOLOGY ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

CRISPR-BASED MOLECULAR DIAGNOSTICS

6.1.1.2

ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

ENVIRONMENTAL & WASTEWATER SURVEILLANCE

6.1.2.2

MICROFLUIDIC SENSORS

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

AI & MACHINE LEARNING

6.1.3.2

MULTIPLEX PCR PANELS

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.2.1

NEAR TERM (2025–2027)

6.2.2

MID TERM (2028–2030)

6.2.3

LONG TERM (2030+)

6.3

PATENT ANALYSIS

6.3.1

PATENT PUBLICATION TRENDS FOR POULTRY DIAGNOSTICS

6.3.2

JURISDICTION & TOP APPLICANT ANALYSIS

6.4

FUTURE APPLICATIONS

6.4.1

PRECISION FLOCK-LEVEL DISEASE PREDICTION

6.4.2

MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS

6.4.3

CONTINUOUS ENVIRONMENTAL & WASTEWATER MONITORING SYSTEMS

6.4.4

MULTIPLEX & SYNDROMIC POULTRY DIAGNOSTIC PANELS

6.4.5

SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING

6.5

IMPACT OF AI/GENERATIVE AI ON POULTRY DIAGNOSTICS MARKET

6.5.1

INTRODUCTION

6.5.2

MARKET POTENTIAL IN POULTRY DIAGNOSTIC ECOSYSTEM

6.5.3

AI USE CASES

6.5.4

KEY COMPANIES IMPLEMENTING AI IN POULTRY DIAGNOSTICS MARKET

SUSTAINABILITY & REGULATORY LANDSCAPE

Navigate evolving regulations and sustainability practices to enhance eco-friendly poultry diagnostic solutions.

111

7.1

REGIONAL REGULATIONS & COMPLIANCE

7.1.1

REGULATORY ANALYSIS

7.1.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.3

INDUSTRY STANDARDS

7.2

SUSTAINABILITY INITIATIVES

7.2.1

RECYCLED AND ECO-FRIENDLY MATERIALS FOR POULTRY DIAGNOSTIC PRODUCTS

7.2.2

SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

7.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Discover unmet needs and decision-making drivers shaping customer choices in diverse industries.

116

8.1

KEY STAKEHOLDERS & BUYING CRITERIA

8.1.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.1.2

BUYING CRITERIA

8.2

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.2.1

DECISION-MAKING PROCESS

8.2.2

ADOPTION BARRIERS & INTERNAL CHALLENGES

8.2.3

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.2.4

MARKET PROFITABILITY

POULTRY DIAGNOSTICS MARKET, BY PRODUCT TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 31 Data Tables

121

9.1

INTRODUCTION

9.2

CONSUMABLES & REAGENTS

9.2.1

ELISA KITS & REAGENTS

9.2.1.1

LARGE-SCALE SEROLOGICAL SURVEILLANCE AND VACCINATION MONITORING TO SUSTAIN DEMAND

9.2.1.2

GLOBAL VOLUME ANALYSIS OF ELISA KITS & REAGENTS, 2024–2031 (THOUSAND UNITS)

9.2.2

PCR KITS & REAGENTS

9.2.2.1

RISING ADOPTION OF MOLECULAR DIAGNOSTICS TO ACCELERATE DEMAND

9.2.2.2

GLOBAL VOLUME ANALYSIS OF PCR KITS & REAGENTS, 2024–2031 (THOUSAND UNITS)

9.2.3

SAMPLE PREPARATION & EXTRACTION KITS

9.2.3.1

INCREASING USE OF MOLECULAR TESTING TO FUEL MARKET GROWTH

9.2.3.2

GLOBAL VOLUME ANALYSIS OF SAMPLE PREPARATION & EXTRACTION KITS, 2024–2031 (THOUSAND UNITS)

9.2.4

CONTROLS & LABORATORY CONSUMABLES

9.2.4.1

EXPANDING DIAGNOSTIC TEST VOLUMES TO DRIVE CONSISTENT DEMAND

9.2.4.2

GLOBAL VOLUME ANALYSIS OF CONTROLS & LABORATORY CONSUMABLES, 2024–2031 (THOUSAND UNITS)

9.3

INSTRUMENTS

9.3.1

PCR INSTRUMENTS

9.3.1.1

GROWING NEED FOR RAPID AND HIGH-SENSITIVITY PATHOGEN DETECTION TO BOOST MARKET

9.3.1.2

GLOBAL VOLUME ANALYSIS OF PCR INSTRUMENTS, 2024–2031 (THOUSAND UNITS)

9.3.2

ELISA READERS & WASHERS

9.3.2.1

HIGH-THROUGHPUT SEROLOGICAL TESTING TO SUPPORT CONTINUED USE OF ELISA READERS

9.3.2.2

GLOBAL VOLUME ANALYSIS OF ELISA READERS & WASHERS, 2024–2031 (THOUSAND UNITS)

9.3.3

NUCLEIC ACID EXTRACTION SYSTEMS

9.3.3.1

RISING MOLECULAR TESTING WORKFLOWS TO DRIVE ADOPTION

9.3.3.2

GLOBAL VOLUME ANALYSIS OF NUCLEIC ACID EXTRACTION SYSTEMS, 2024–2031 (THOUSAND UNITS)

9.3.4

OTHER LABORATORY AUTOMATION INSTRUMENTS

9.3.4.1

GLOBAL VOLUME ANALYSIS OF OTHER LABORATORY AUTOMATION INSTRUMENTS, 2024–2031 (THOUSAND UNITS)

POULTRY DIAGNOSTICS MARKET, BY TEST TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 49 Data Tables

149

10.1

INTRODUCTION

10.2

PCR-BASED DIAGNOSTICS

10.2.1

AVIAN INFLUENZA PCR PANELS

10.2.1.1

GLOBAL SURVEILLANCE PROGRAMS AND OUTBREAK MONITORING TO BOOST DEMAND

10.2.1.2

GLOBAL VOLUME ANALYSIS OF AVIAN INFLUENZA PCR PANELS, 2024–2031 (THOUSAND TESTS)

10.2.1.3

GLOBAL VOLUME ANALYSIS OF AVIAN INFLUENZA PCR PANELS, 2024–2031 (THOUSAND ANIMALS)

10.2.2

NEWCASTLE DISEASE PCR PANELS

10.2.2.1

HIGH TRANSMISSIBILITY OF NEWCASTLE DISEASE TO INCREASE RELIANCE ON MOLECULAR PCR DETECTION

10.2.2.2

GLOBAL VOLUME ANALYSIS OF NEWCASTLE DISEASE PCR PANELS, 2024–2031 (THOUSAND TESTS)

10.2.2.3

GLOBAL VOLUME ANALYSIS OF NEWCASTLE DISEASE PCR PANELS, 2024–2031 (THOUSAND ANIMALS)

10.2.3

ENDEMIC VIRAL PCR PANELS

10.2.3.1

ROUTINE FLOCK HEALTH MONITORING TO ACCELERATE USE OF MULTIPLEX ENDEMIC VIRAL PCR PANELS

10.2.3.2

GLOBAL VOLUME ANALYSIS OF ENDEMIC VIRAL PCR PANELS, 2024–2031 (THOUSAND TESTS)

10.2.3.3

GLOBAL VOLUME ANALYSIS OF ENDEMIC VIRAL PCR PANELS, 2024–2031 (THOUSAND ANIMALS)

10.2.4

MYCOPLASMA PCR PANELS

10.2.4.1

NEED FOR EARLY IDENTIFICATION OF MYCOPLASMA INFECTIONS TO DRIVE ADOPTION

10.2.4.2

GLOBAL VOLUME ANALYSIS OF MYCOPLASMA PCR PANELS, 2024–2031 (THOUSAND TESTS)

10.2.4.3

GLOBAL VOLUME ANALYSIS OF MYCOPLASMA PCR PANELS, 2024–2031 (THOUSAND ANIMALS)

10.2.5

BACTERIAL PCR PANELS

10.2.5.1

INCREASING FOCUS ON PATHOGEN DETECTION AND FOOD SAFETY TO SUPPORT MARKET GROWTH

10.2.5.2

GLOBAL VOLUME ANALYSIS OF BACTERIAL PCR PANELS, 2024–2031 (THOUSAND TESTS)

10.2.5.3

GLOBAL VOLUME ANALYSIS OF BACTERIAL PCR PANELS, 2024–2031 (THOUSAND ANIMALS)

10.3

ELISA-BASED DIAGNOSTICS

10.3.1

ENDEMIC VIRAL ELISA TESTS

10.3.1.1

ROUTINE IMMUNITY MONITORING IN POULTRY FLOCKS TO DRIVE DEMAND

10.3.1.2

GLOBAL VOLUME ANALYSIS OF ENDEMIC VIRAL ELISA TESTS, 2024–2031 (THOUSAND TESTS)

10.3.1.3

GLOBAL VOLUME ANALYSIS OF ENDEMIC VIRAL ELISA TESTS, 2024–2031 (THOUSAND ANIMALS)

10.3.2

AVIAN INFLUENZA ELISA TESTS

10.3.2.1

LARGE-SCALE SEROLOGICAL SURVEILLANCE PROGRAMS TO SUPPORT USE OF AVIAN INFLUENZA ELISA ASSAYS

10.3.2.2

GLOBAL VOLUME ANALYSIS OF AVIAN INFLUENZA ELISA TESTS, 2024–2031 (THOUSAND TESTS)

10.3.2.3

GLOBAL VOLUME ANALYSIS OF AVIAN INFLUENZA ELISA TESTS, 2024–2031 (THOUSAND ANIMALS)

10.3.3

NEWCASTLE DISEASE ELISA TESTS

10.3.3.1

VACCINATION MONITORING AND FLOCK IMMUNITY ASSESSMENT TO FUEL DEMAND

10.3.3.2

GLOBAL VOLUME ANALYSIS OF NEWCASTLE DISEASE ELISA TESTS, 2024–2031 (THOUSAND TESTS)

10.3.3.3

GLOBAL VOLUME ANALYSIS OF NEWCASTLE DISEASE ELISA TESTS, 2024–2031 (THOUSAND ANIMALS)

10.3.4

MYCOPLASMA ELISA TESTS

10.3.4.1

ONGOING FLOCK HEALTH SURVEILLANCE TO INCREASE ADOPTION OF MYCOPLASMA ELISA TESTING

10.3.4.2

GLOBAL VOLUME ANALYSIS OF MYCOPLASMA ELISA TESTS, 2024–2031 (THOUSAND TESTS)

10.3.4.3

GLOBAL VOLUME ANALYSIS OF MYCOPLASMA ELISA TESTS, 2024–2031 (THOUSAND ANIMALS)

10.3.5

BACTERIAL ELISA TESTS

10.3.5.1

GROWING EMPHASIS ON BACTERIAL DISEASE CONTROL TO SUPPORT USE OF BACTERIAL ELISA DIAGNOSTICS

10.3.5.2

GLOBAL VOLUME ANALYSIS OF BACTERIAL ELISA TESTS, 2024–2031 (THOUSAND TESTS)

10.3.5.3

GLOBAL VOLUME ANALYSIS OF BACTERIAL ELISA TESTS, 2024–2031 (THOUSAND ANIMALS)

10.4

OTHER DIAGNOSTIC TESTS

POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 15 Data Tables

190

11.1

INTRODUCTION

11.2

AVIAN INFLUENZA

11.2.1

GLOBAL SURVEILLANCE PROGRAMS AND FREQUENT HPAI OUTBREAKS TO DRIVE DEMAND

11.3

NEWCASTLE DISEASE

11.3.1

HIGH CONTAGIOUSNESS AND ONGOING OUTBREAK RISKS TO FUEL MARKET GROWTH

11.4

INFECTIOUS BRONCHITIS

11.4.1

EMERGENCE OF MULTIPLE IBV VARIANTS TO INCREASE DEMAND FOR DIAGNOSTICS

11.5

AVIAN MYCOPLASMOSIS

11.5.1

RISING FOCUS ON RESPIRATORY DISEASE CONTROL TO BOOST ADOPTION

11.6

SALMONELLOSIS

11.6.1

INCREASING FOOD SAFETY REGULATIONS AND SURVEILLANCE PROGRAMS TO BOOST MARKET GROWTH

11.7

INFECTIOUS BURSAL DISEASE

11.7.1

NEED TO MONITOR IMMUNOSUPPRESSIVE VIRAL INFECTIONS TO DRIVE DEMAND

11.8

OTHER INFECTIOUS DISEASES

POULTRY DIAGNOSTICS MARKET, BY POULTRY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables

208

12.1

INTRODUCTION

12.2

PCR-BASED DIAGNOSTICS

12.2.1

BROILERS

12.2.1.1

HIGH-DENSITY MEAT PRODUCTION SYSTEMS TO DRIVE STRONG ADOPTION OF PCR TESTING

12.2.2

LAYERS

12.2.2.1

NEED FOR RAPID DETECTION OF DISEASES AFFECTING EGG PRODUCTION TO SUPPORT MARKET GROWTH

12.2.3

BREEDERS

12.2.3.1

PREVENTION OF VERTICAL PATHOGEN TRANSMISSION TO DRIVE EXTENSIVE PCR SURVEILLANCE

12.2.4

TURKEYS

12.2.4.1

DISEASE MONITORING IN COMMERCIAL TURKEY PRODUCTION TO SUPPORT ADOPTION

12.2.5

DUCKS & GEESE

12.2.5.1

ROLE OF WATERFOWL IN AVIAN INFLUENZA SURVEILLANCE TO INCREASE PCR TESTING

12.2.6

OTHER POULTRY

12.3

ELISA-BASED DIAGNOSTICS

12.3.1

BROILERS

12.3.1.1

MONITORING VACCINE-INDUCED IMMUNITY TO DRIVE ELISA-BASED SEROLOGICAL TESTING

12.3.2

LAYERS

12.3.2.1

LONG PRODUCTION CYCLES AND EGG YIELD MONITORING TO SUPPORT MARKET GROWTH

12.3.3

BREEDERS

12.3.3.1

ROUTINE ANTIBODY MONITORING FOR DISEASE-FREE BREEDING PROGRAMS TO DRIVE ELISA TESTING

12.3.4

TURKEYS

12.3.4.1

NEED FOR EFFECTIVE VACCINATION MONITORING TO SUPPORT ELISA-BASED DIAGNOSTICS

12.3.5

DUCKS & GEESE

12.3.5.1

SEROLOGICAL SURVEILLANCE OF WATERFOWL POPULATIONS TO BOOST MARKET GROWTH

12.3.6

OTHER POULTRY

12.4

OTHER DIAGNOSTIC TESTS

12.4.1

BROILERS

12.4.1.1

RAPID SCREENING AND CONFIRMATORY TESTING TO REQUIRE CONVENTIONAL DIAGNOSTICS

12.4.2

LAYERS

12.4.2.1

LONG-TERM FLOCK MONITORING TO DRIVE CONTINUED USE OF TRADITIONAL DIAGNOSTIC TESTS

12.4.3

BREEDERS

12.4.3.1

ESTABLISHED SEROLOGICAL METHODS TO SUPPORT DISEASE SURVEILLANCE IN BREEDER FLOCKS

12.4.4

TURKEYS

12.4.4.1

ROUTINE DISEASE SCREENING AND PATHOGEN IDENTIFICATION TO SUSTAIN USE OF CONVENTIONAL DIAGNOSTICS

12.4.5

DUCKS & GEESE

12.4.5.1

SURVEILLANCE OF WATERFOWL-ASSOCIATED PATHOGENS TO MAINTAIN USE OF TRADITIONAL DIAGNOSTIC METHODS

12.4.6

OTHER POULTRY

POULTRY DIAGNOSTICS MARKET, BY SAMPLE TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables

240

13.1

INTRODUCTION

13.2

SWABS

13.2.1

EASE OF COLLECTION AND SUITABILITY FOR MOLECULAR TESTING TO DRIVE WIDESPREAD USE OF SWAB SAMPLES

13.3

SERUM/BLOOD

13.3.1

GROWING FOCUS ON FLOCK IMMUNITY MONITORING AND VACCINATION ASSESSMENT TO SUPPORT DEMAND

13.4

TISSUE SAMPLES

13.4.1

NEED FOR CONFIRMATORY DIAGNOSIS AND DETAILED PATHOLOGICAL INVESTIGATION TO DRIVE MARKET GROWTH

13.5

ENVIRONMENTAL & FECAL SAMPLES

13.5.1

RISING EMPHASIS ON FARM-LEVEL SURVEILLANCE AND BIOSECURITY MONITORING TO BOOST ADOPTION

POULTRY DIAGNOSTICS MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables

248

14.1

INTRODUCTION

14.2

VETERINARY DIAGNOSTIC LABORATORIES

14.2.1

CENTRAL ROLE IN DISEASE SURVEILLANCE AND HIGH TESTING VOLUMES TO DRIVE DEMAND

14.3

INTEGRATED POULTRY PRODUCERS

14.3.1

GROWING VERTICAL INTEGRATION AND NEED FOR CONTINUOUS FLOCK MONITORING TO INCREASE DIAGNOSTIC ADOPTION

14.4

GOVERNMENT & REFERENCE LABORATORIES

14.4.1

NATIONAL DISEASE SURVEILLANCE PROGRAMS AND REGULATORY TESTING REQUIREMENTS TO BOOST MARKET GROWTH

14.5

ACADEMIC & RESEARCH INSTITUTIONS

14.5.1

RISING RESEARCH ON POULTRY PATHOGENS AND DIAGNOSTIC INNOVATION TO SUPPORT DEMAND

14.6

OTHER SPECIALIZED LABORATORIES

14.6.1

INCREASING OUTSOURCING OF ADVANCED TESTING SERVICES TO DRIVE DEMAND

POULTRY DIAGNOSTICS MARKET, BY REGION

Comprehensive coverage of 9 Regions with country-level deep-dive of 23 Countries | 481 Data Tables.

258

15.1

INTRODUCTION

15.2

NORTH AMERICA

15.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

15.2.2

NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

15.2.3

NORTH AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031

15.2.4

15.2.4.1

LARGE-SCALE POULTRY PRODUCTION TO DRIVE DEMAND FOR POULTRY DIAGNOSTIC TESTING

15.2.5

CANADA

15.2.5.1

STRONG BIOSECURITY REGULATIONS AND EXPANDING POULTRY PRODUCTION TO DRIVE MARKET

15.3

EUROPE

15.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

15.3.2

EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

15.3.3

EUROPE: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031

15.3.4

GERMANY

15.3.4.1

GERMANY TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD

15.3.5

15.3.5.1

ROBUST DISEASE SURVEILLANCE PROGRAMS TO DRIVE MARKET GROWTH

15.3.6

FRANCE

15.3.6.1

FREQUENT AVIAN INFLUENZA OUTBREAKS AND LARGE POULTRY PRODUCTION SYSTEMS TO FUELS MARKET GROWTH

15.3.7

ITALY

15.3.7.1

GROWING POULTRY PRODUCTION TO SUPPORT MARKET GROWTH

15.3.8

SPAIN

15.3.8.1

EXPANDING BROILER PRODUCTION AND INCREASING DISEASE SURVEILLANCE TO DRIVE MARKET GROWTH

15.3.9

NETHERLANDS

15.3.9.1

ADVANCED VETERINARY SURVEILLANCE INFRASTRUCTURE TO DRIVE MARKET GROWTH

15.3.10

POLAND

15.3.10.1

RAPID EXPANSION OF POULTRY PRODUCTION AND EXPORT-ORIENTED FARMING TO INCREASE DEMAND

15.3.11

RUSSIA

15.3.11.1

EXPANDING DOMESTIC POULTRY PRODUCTION TO DRIVE MARKET GROWTH

15.3.12

REST OF EUROPE

15.4

ASIA PACIFIC

15.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

15.4.2

ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

15.4.3

ASIA PACIFIC: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031

15.4.4

CHINA

15.4.4.1

CHINA TO DOMINATE APAC MARKET DURING FORECAST PERIOD

15.4.5

JAPAN

15.4.5.1

RECURRING AVIAN INFLUENZA OUTBREAKS TO DRIVE MARKET

15.4.6

INDIA

15.4.6.1

RAPIDLY EXPANDING POULTRY INDUSTRY AND INCREASING DISEASE SURVEILLANCE INITIATIVES TO BOOST MARKET GROWTH

15.4.7

AUSTRALIA

15.4.7.1

STRONG BIOSECURITY REGULATIONS AND ADVANCED POULTRY PRODUCTION SYSTEMS TO SUPPORT MARKET GROWTH

15.4.8

SOUTH KOREA

15.4.8.1

FREQUENT AVIAN INFLUENZA OUTBREAKS AND INTENSIVE POULTRY FARMING TO BOOST MARKET GROWTH

15.4.9

THAILAND

15.4.9.1

EXPORT-ORIENTED POULTRY PRODUCTION TO DRIVE MARKET

15.4.10

NEW ZEALAND

15.4.10.1

STRICT BIOSECURITY SYSTEMS AND PREVENTIVE DISEASE SURVEILLANCE PROGRAMS TO SUPPORT MARKET GROWTH

15.4.11

INDONESIA

15.4.11.1

LARGE POULTRY POPULATION TO FUEL MARKET GROWTH

15.4.12

PHILIPPINES

15.4.12.1

EXPANDING POULTRY PRODUCTION AND RISING DISEASE MONITORING EFFORTS TO DRIVE ADOPTION

15.4.13

REST OF ASIA PACIFIC

15.5

LATIN AMERICA

15.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

15.5.2

LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

15.5.3

LATIN AMERICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031

15.5.4

BRAZIL

15.5.4.1

LARGE-SCALE POULTRY PRODUCTION AND EXPORT-DRIVEN POULTRY INDUSTRY TO DRIVE DEMAND

15.5.5

MEXICO

15.5.5.1

STRONG DOMESTIC POULTRY CONSUMPTION TO CONTRIBUTE TO MARKET GROWTH

15.5.6

ARGENTINA

15.5.6.1

EXPANDING POULTRY PRODUCTION AND INCREASED DISEASE MONITORING TO DRIVE MARKET

15.5.7

REST OF LATIN AMERICA

15.6

MIDDLE EAST & AFRICA

15.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

15.6.2

MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031

15.6.3

MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY TEST TYPE, 2024–2031

15.6.4

GCC COUNTRIES

15.6.4.1

KINGDOM OF SAUDI ARABIA (KSA)

15.6.4.1.1

EXPANDING DOMESTIC POULTRY PRODUCTION AND NATIONAL FOOD SECURITY INITIATIVES TO BOOST GROWTH

15.6.4.2

UNITED ARAB EMIRATES (UAE)

15.6.4.2.1

INCREASING INVESTMENTS IN POULTRY FARMING TO FUEL UAE'S MARKET GROWTH

15.6.4.3

REST OF GCC COUNTRIES

15.6.5

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Uncover market leaders' strategies and growth trajectories shaping the competitive landscape through 2025.

494

16.1

OVERVIEW

16.2

KEY PLAYER STRATEGY/RIGHT TO WIN

16.3

REVENUE ANALYSIS, 2021−2025

16.4

MARKET SHARE ANALYSIS, 2025

16.4.1

US MARKET SHARE ANALYSIS, 2025

16.4.2

EUROPE MARKET SHARE ANALYSIS, 2025

16.4.3

RANKING OF KEY MARKET PLAYERS

16.5

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025

16.5.1

STARS

16.5.2

EMERGING LEADERS

16.5.3

PERVASIVE PLAYERS

16.5.4

PARTICIPANTS

16.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

16.5.5.1

COMPANY FOOTPRINT

16.5.5.2

REGION FOOTPRINT

16.5.5.3

PRODUCT TYPE FOOTPRINT

16.5.5.4

TEST TYPE FOOTPRINT

16.5.5.5

DISEASE TYPE FOOTPRINT

16.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

16.6.1

PROGRESSIVE COMPANIES

16.6.2

RESPONSIVE COMPANIES

16.6.3

DYNAMIC COMPANIES

16.6.4

STARTING BLOCKS

16.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

16.6.5.1

DETAILED LIST OF KEY STARTUPS/SMES

16.6.5.2

COMPETITIVE BENCHMARKING OF KEY STARTUPS

16.7

BRAND/PRODUCT COMPARISON

16.8

R&D EXPENDITURE OF KEY PLAYERS

16.9

COMPANY VALUATION & FINANCIAL METRICS

16.9.1

FINANCIAL METRICS

16.9.2

COMPANY VALUATION

16.10

COMPETITIVE SCENARIO

16.10.1

PRODUCT LAUNCHES

16.10.2

DEALS

16.10.3

EXPANSIONS

16.10.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

518

17.1

KEY PLAYERS

17.1.1

IDEXX LABORATORIES, INC.

17.1.1.1

BUSINESS OVERVIEW

17.1.1.2

PRODUCTS OFFERED

17.1.1.3

MNM VIEW

17.1.1.3.1

KEY STRENGTHS

17.1.1.3.2

STRATEGIC CHOICES

17.1.1.3.3

WEAKNESSES & COMPETITIVE THREATS

17.1.2

THERMO FISHER SCIENTIFIC INC.

17.1.3

ZOETIS SERVICES LLC

17.1.4

BIOCHEK

17.1.5

INNOVATIVE DIAGNOSTICS

17.1.6

BIONOTE

17.1.7

BIO-RAD LABORATORIES, INC.

17.1.8

17.1.9

INDICAL BIOSCIENCE GMBH

17.1.10

SHENZHEN BIOEASY BIOTECHNOLOGY, INC.

17.1.11

RING BIOTECHNOLOGY CO., LTD.

17.1.12

BIO-X DIAGNOSTICS S.A.

17.1.13

MEGACOR DIAGNOSTIK GMBH

17.1.14

GOLD STANDARD DIAGNOSTICS

17.1.15

BIONEER CORPORATION

17.2

OTHER PLAYERS

17.2.1

ELABSCIENCE, INC.

17.2.2

BIOSELLAL

17.2.3

BIOGAL

17.2.4

BIOSTONE ANIMAL HEALTH

17.2.5

UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.

17.2.6

ABBEXA

17.2.7

BIOINGENTECH

17.2.8

AFFIGEN INC.

17.2.9

ALVEO TECHNOLOGIES

17.2.10

HIMEDIA LABORATORIES

RESEARCH METHODOLOGY

582

18.1

RESEARCH DATA

18.2

RESEARCH METHODOLOGY DESIGN

18.2.1

SECONDARY DATA

18.2.1.1

KEY DATA FROM SECONDARY SOURCES

18.2.2

PRIMARY DATA

18.2.2.1

KEY DATA FROM PRIMARY SOURCES

18.2.2.2

KEY INDUSTRY INSIGHTS

18.3

MARKET SIZE ESTIMATION

18.3.1

BOTTOM-UP APPROACH

18.4

MARKET BREAKDOWN & DATA TRIANGULATION

18.5

MARKET SHARE ANALYSIS

18.5.1

RESEARCH ASSUMPTIONS

18.5.2

GROWTH RATE ASSUMPTIONS

18.6

RISK ASSESSMENT

18.7

RESEARCH LIMITATIONS

18.7.1

METHODOLOGY-RELATED LIMITATIONS

18.7.2

SCOPE-RELATED LIMITATIONS

APPENDIX

599

19.1

DISCUSSION GUIDE

19.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

19.3

CUSTOMIZATION OPTIONS

19.3.1

PRODUCT ANALYSIS

19.3.2

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the poultry diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the poultry diagnostics market. Primary sources from the demand side include poultry veterinarians, managers of commercial poultry farms and integrators, directors of veterinary diagnostic laboratories, officials from government animal health agencies, and procurement and purchasing teams.

Breakdown of Primary Respondents:

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the poultry diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Market Definition

The poultry diagnostics market comprises products and services used for the detection, identification, and monitoring of infectious diseases in poultry species, including broilers, layers, and breeders. It includes diagnostic kits, reagents, consumables, instruments, and laboratory services based on technologies such as PCR, ELISA, rapid immunoassays, and other molecular and serological methods. These solutions are utilized by veterinary diagnostic laboratories, commercial poultry producers, research institutions, and government agencies for routine surveillance, outbreak confirmation, biosecurity compliance, and export certification. The market supports early disease detection, flock health management, and control of transboundary and endemic poultry diseases.

Stakeholders

Poultry diagnostic kit manufacturers (ELISA, PCR, rapid tests)
Molecular technology providers & instrument manufacturers
Reagent & consumable suppliers
Veterinary diagnostic laboratories (private & public)
Government animal health authorities & surveillance agencies
Integrated poultry producers & commercial farms
Poultry veterinarians & technical service providers
Academic & veterinary research institutions
Contract manufacturers & OEM partners
Distributors & regional channel partners
Market research & consulting firms
Investors & venture capital firms

Report Objectives

To define, describe, segment, and forecast the poultry diagnostics market by product type, test type, disease type, poultry type, sample type, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall poultry diagnostics market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the poultry diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the poultry diagnostics market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031

OVERVIEW

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Rising incidence of transboundary & endemic diseases

Restraint: High cost of advanced molecular testing platforms

Opportunity: Geographic expansion in emerging poultry markets

Challenge: Rapid mutation and strain variability of viral pathogens

POULTRY DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Poultry Diagnostics Market, by Product Type

Poultry Diagnostics Market, by Test Type

Poultry Diagnostics Market, by Disease Type

Poultry Diagnostics Market, by Poultry Type

Poultry Diagnostics Market, by Sample Type

Poultry Diagnostics Market, by End User

REGION

Asia Pacific to be fastest-growing region in global poultry diagnostics market during forecast period

POULTRY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: POULTRY DIAGNOSTICS MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Stakeholders

Report Objectives

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Poultry Diagnostics Market